The Yogi Adityanath government 2.0 is pitching Uttar Pradesh as a pharmaceutical and medical devices hub in India.
The state has earmarked 2,350 acres for developing pharma and biotech parks across the state. These hubs will come up in Lalitpur, Pilibhit and Gautam Buddha Nagar (Noida) districts.
Earlier, UP chief minister Yogi Adityanath talked about hiking the state’s contribution to pharma industry from 2 percent to almost 12 percent.
With these mega pharma projects, UP aims at catering the domestic market and also tap the global pharma and medical export markets. The domestic pharma industry, valued at $42 billion in 2021, is projected to hit $130 billion by 2030.
Currently, pharma shipments from India are valued at $25 billion. Indian pharma industry is among the top three globally in terms of volume. India is also the global leader in supplying generic medicines, commanding a 20 percent market share.
Meanwhile, a pharma park covering 2,000 acres will come up in Lalitpur. It will be dedicated to bulk drugs, starting/raw materials and active pharmaceuticals under the new UP Pharma Policy 2023.
Besides, a medical devices park, spread over 350 acres in Sector 28 of the Yamuna Expressway Industrial Development Authority (YEIDA) in Greater Noida, is also proposed.
It will house 100+ medical equipment and devices manufacturing units. They will manufacture an array of medical devices including orthopedic implants, oxygen concentrator, anaesthesia needle & kit, anaesthesia workstation, spinal implant, X- ray machine, endoscopic, biliary stent, ICU ventilator, ECG machine, chemotherapy device, radiology device etc.
By importing almost 80 percent of medical devices requirement, India is dependent on foreign suppliers, particularly high end equipment viz. cancer diagnostics, medical imaging, ultrasonic scans etc.
Moreover, UP is looking to develop a biotech park in Pilibhit district to aid the state in cutting down on import of fermentation-based goods.